Skip to main content

J&J Scores in The First Mesothelioma Trial

J&J Scores in The First Mesothelioma Trial

J&J Scores in The First Mesothelioma Trial

Introduction

Although J&J is witnessing a 'win some - lose some' situation in the ovarian cancer lawsuits linked to its Talcum Powder and Shower to Shower talc products, it won the first Mesothelioma case. The decision was taken by a jury in Los Angeles Superior Court rejecting the plaintiff's claim that she developed mesothelioma (a type of cancer of the tissue that lines the lungs, stomach, heart, and other organs) after using J&J's Talcum Powder.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!